beta-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study.
(49/75)
(+info )Invasive candidiasis: a review of nonculture-based laboratory diagnostic methods.
(50/75)
(+info )Optimizing Echinocandin dosing and susceptibility breakpoint determination via in vivo pharmacodynamic evaluation against Candida glabrata with and without fks mutations.
(51/75)
(+info )Efficacy and safety of anidulafungin in elderly, critically ill patients with invasive Candida infections: a post hoc analysis.
(52/75)
(+info )Risk factors for invasive candidiasis in infants >1500 g birth weight.
(53/75)
(+info )Population pharmacokinetic-pharmacodynamic analysis of anidulafungin in adult patients with fungal infections.
(54/75)
(+info )Candiduria in haematologic malignancy patients without a urinary catheter: nothing more than a frailty marker?
(55/75)
(+info )Treatment and prophylaxis of invasive candidiasis.
(56/75)
(+info )